Cai Li

Cai Li serves as the Head of CVM Discovery and Strategy & Portfolio at the China Innovation Center of Roche since September 2021, focusing on the strategic and operational aspects of Roche's next-generation R&D engine. Previously, Cai Li held various positions at Merck, including Acting Diabetes Department Head, where responsibilities included overseeing drug discovery and development portfolios, and External In Vivo Pharmacology Lead - Oncology, managing global studies. An academic career began with a role as Assistant Professor at The University of Texas Southwestern Medical Center, where significant research funding was secured. Educational qualifications include a B.S. in Biology from Northeast Normal University, a degree in Virology from Southern Illinois University, and a Ph.D. in Neuroscience from UT Southwestern Medical Center.